Significant progress has been made in characterizing the biological changes occurring in preclinical Alzheimer’s disease (AD). Cognitive dysfunction has been viewed, however, as a late-stage phenomenon, despite increasing evidence that changes may be detected in the decades preceding dementia. In the absence of comprehensive evidence-based guidelines for preclinical cognitive assessment, longitudinal cohort and neuroimaging studies have been reviewed to determine the temporal order and brain biomarker correlates of specific cognitive functions.
from Dementia Big http://ift.tt/2dlYEwJ via alcoholic dementia
http://ift.tt/2dnSNqi
No comments:
Post a Comment